CAM-L-4677-18 - Matthew Enriqguez, individually and on behalf of all others similarly situated V. Johnson & Johnson; Janssen Pharmaceuticals, Inc.; ACTA VIS Pharma, Inc.; and ACTA VIS LLC
Business Opinion Category
Complex Business Litigation Program
Decided Date
Oct. 10, 2019
Oct. 10, 2019
Business Opinion Issue Types
Consumer Fraud
Tortious Interference
Unjust Enrichment
Publication Status
Unpublished
Unpublished
Judge
Polansky, P.J.Cv
Referenced Opinion ID
CAM-L-4677-18
CAM-L-4677-18